Acorda Therapeutics to Present at the J.P. Morgan SMid Cap Conference

HAWTHORNE, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that Ron Cohen, M.D., President & CEO, will present at the upcoming J.P. Morgan SMid Cap Conference on Thursday, December 02, 2010 at 12:45 p.m. Eastern Time at J.P. Morgan Conference Center in New York, NY.

MORE ON THIS TOPIC